Dupilumab, a Monoclonal Antibody for Atopic DermatitisDupilumab, a Monoclonal Antibody for Atopic Dermatitis
Learn about a novel biological therapy for atopic eczema, dupilumab, which is on a fast-track to FDA approval. How is it clarifying our understanding of the pathogenesis of this chronic disease? Skin Therapy Letter
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news
More News: Allergy | Allergy & Immunology | Dermatitis | Dermatology | Eczema | Learning | Skin | Universities & Medical Training